Clinical Trial Update: Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the efficacy and safety of GW642444M versus placebo in adolescents and adults with persistent asthma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GW642444M (GW642444M)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-08-12